Literature DB >> 9836370

Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies.

E M Paleolog1, R A Fava.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9836370     DOI： 10.1007/bf00832000

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  95 in total

Review 1.  Hypoxia and inflammatory synovitis: observations and speculation.

Authors:  C R Stevens; R B Williams; A J Farrell; D R Blake
Journal:  Ann Rheum Dis       Date:  1991-02       Impact factor: 19.103

Review 2.  The heparin-binding (fibroblast) growth factor family of proteins.

Authors:  W H Burgess; T Maciag
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

3.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

4.  Hypoxic-reperfusion injury in the inflamed human joint.

Authors:  D R Blake; P Merry; J Unsworth; B L Kidd; J M Outhwaite; R Ballard; C J Morris; L Gray; J Lunec
Journal:  Lancet       Date:  1989-02-11       Impact factor: 79.321

5.  Chondrocytes inhibit endothelial sprout formation in vitro: evidence for involvement of a transforming growth factor-beta.

Authors:  M S Pepper; R Montesano; J D Vassalli; L Orci
Journal:  J Cell Physiol       Date:  1991-01       Impact factor: 6.384

6.  Significant correlation between thrombospondin 1 and serine proteinase expression in rheumatoid synovium.

Authors:  I Gotis-Graham; P J Hogg; H P McNeil
Journal:  Arthritis Rheum       Date:  1997-10

7.  Coexpression of phosphotyrosine-containing proteins, platelet-derived growth factor-B, and fibroblast growth factor-1 in situ in synovial tissues of patients with rheumatoid arthritis and Lewis rats with adjuvant or streptococcal cell wall arthritis.

Authors:  H Sano; K Engleka; P Mathern; T Hla; L J Crofford; E F Remmers; C L Jelsema; E Goldmuntz; T Maciag; R L Wilder
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia.

Authors:  R A Fava; N J Olsen; A E Postlethwaite; K N Broadley; J M Davidson; L B Nanney; C Lucas; A S Townes
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

9.  Suppression of arthritis by an inhibitor of nitric oxide synthase.

Authors:  N McCartney-Francis; J B Allen; D E Mizel; J E Albina; Q W Xie; C F Nathan; S M Wahl
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

10.  Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane.

Authors:  E Y Yang; H L Moses
Journal:  J Cell Biol       Date:  1990-08       Impact factor: 10.539
View more
  15 in total

Review 1.  Angiogenesis as a target in rheumatoid arthritis.

Authors:  A E Koch
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

Review 2.  New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders.

Authors:  S C Ballara; J M Miotla; E M Paleolog
Journal:  Int J Exp Pathol       Date:  1999-10       Impact factor: 1.925

3.  Visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with etanercept.

Authors:  V Bagalas; I Kioumis; P Argyropoulou; D Patakas
Journal:  Clin Rheumatol       Date:  2006-07-25       Impact factor: 2.980

4.  Novel acetamide derivatives of 2-aminobenzimidazole prevent inflammatory arthritis in rats via suppression of pro-inflammatory mediators.

Authors:  Aymun Madni Zubair; Muhammad Nasir Hayat Malik; Waqas Younis; Muhammad Atif Hayat Malik; Shah Jahan; Ishtiaq Ahmed; Alamgeer Yuchi; Muhammad Naveed Mushtaq; Romeeza Tahir; Muhammad Bilal Sarwar; Muhammad Roman; Ayaz Ali Khan; Muhammad Nouman Tahir; Muhammad Tariq Khan; Hafiz Amir Ali Kharl; Gagun Kamran; Abdullah Abdo Albegali; Ali Imran
Journal:  Inflammopharmacology       Date:  2022-04-16       Impact factor: 4.473

5.  Thrombospondin 2 functions as an endogenous regulator of angiogenesis and inflammation in rheumatoid arthritis.

Authors:  Yong Wook Park; Young Mo Kang; Joe Butterfield; Michael Detmar; Jörg J Goronzy; Cornelia M Weyand
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 6.  Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.

Authors:  Wiebke Ulbrich; Alf Lamprecht
Journal:  J R Soc Interface       Date:  2009-11-25       Impact factor: 4.118

7.  The anti-malaria agent artesunate inhibits expression of vascular endothelial growth factor and hypoxia-inducible factor-1α in human rheumatoid arthritis fibroblast-like synoviocyte.

Authors:  Ya He; Jinjin Fan; Haobo Lin; Xiuyan Yang; Yujin Ye; Liuqin Liang; Zhongping Zhan; Xiuqing Dong; Lin Sun; Hanshi Xu
Journal:  Rheumatol Int       Date:  2009-10-27       Impact factor: 2.631

8.  Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy.

Authors:  Jungyeon Hwang; Kathleen Rodgers; James C Oliver; Thomas Schluep
Journal:  Int J Nanomedicine       Date:  2008

Review 9.  Chemokines and angiogenesis in rheumatoid arthritis.

Authors:  Zoltan Szekanecz; Angela Pakozdi; Agnes Szentpetery; Timea Besenyei; Alisa E Koch
Journal:  Front Biosci (Elite Ed)       Date:  2009-06-01

Review 10.  Chemokines and chemokine receptors in arthritis.

Authors:  Zoltan Szekanecz; Aniko Vegvari; Zoltan Szabo; Alisa E Koch
Journal:  Front Biosci (Schol Ed)       Date:  2010-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.